NCT01467115 Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT01466244 Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397 Status COMPLETED Phase N/A
NCT01451632 A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers Status COMPLETED Phase PHASE1
NCT01450319 Cetuximab in Refractory Colorectal Cancer With K-RAS Mutated and Favorable FcγRIIa (CD32) Genotype Status COMPLETED Phase PHASE2
NCT01445405 Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT01442935 Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases Status COMPLETED Phase PHASE2
NCT01442649 Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab Status COMPLETED Phase PHASE2
NCT01437449 Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN) Status COMPLETED Phase PHASE2
NCT01435252 A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab Status COMPLETED Phase PHASE2
NCT01427205 Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC) Status WITHDRAWN Phase PHASE2
NCT01412229 Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE2
NCT01388790 Cetuximab in Combination With S-1 and Cisplatin in Gastric Cancer Status COMPLETED Phase PHASE2
NCT01382407 Does Acne Rash During Adolescence Predict Skin Reaction to Cetuximab Status COMPLETED Phase N/A
NCT01360086 Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal Junction Status COMPLETED Phase PHASE2
NCT01338558 A Study of Avastin (Bevacizumab) in Combination With mFOLFOX6 in Treatment-Naïve Patients With Metastatic Colorectal Cancer With or Without K-RAS Mutations, and Comparison to Cetuximab Status WITHDRAWN Phase PHASE3
NCT01334177 TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck Status COMPLETED Phase PHASE1
NCT01332266 E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE1/PHASE2
NCT01326923 Induction Chemo Then Concurrent Chemoradiotherapy With Cetuximab in Locally Advanced Head and Neck Squamous Cell Cancer Status TERMINATED Phase PHASE2